Advanced Oncotherapy (AVO) announces that Fairford Capital Ltd, of which Michael Bradfield, a Non-Executive Director of the Company, is the sole beneficial owner, yesterday purchased 750,000 ordinary shares of 1 penny each in the Company at 5.5 pence per Ordinary Share.
Following this transaction, Michael Bradfield now holds 122,768,510 Ordinary Shares representing 8.66% of the issued share capital of the Company.
|
Advanced Oncotherapy Plc |
|
|
Sanjeev Pandya, CEO |
Tel: +44 20 3617 8728 |
|
Nicolas Serandour, CFO |
|
|
Westhouse Securities (Nomad & Joint Broker) |
|
|
Antonio Bossi / David Coaten |
Tel: +44 20 7601 6100 |
|
Beaufort Securities (Joint Broker) |
|
|
Jon Levinson / Elliot Hance |
Tel: +44 20 7382 8300 |
|
Walbrook PR (Financial PR & IR) |
Tel: +44 20 7933 8780 or avo@walbrookpr.com |
|
Paul McManus / Anna Dunphy
Brand Communications Alan Green |
Mob: +44 7980 541 893 / Mob: +44 7876 741 001
Tel: +44 1273 704473 Mob: +44 7976 431608 |